TITLE

Tiotropium improves lung function and reduces COPD exacerbations

AUTHOR(S)
Mayor, Susan
PUB. DATE
November 2008
SOURCE
British Journal of Hospital Medicine (17508460);Nov2008, Vol. 69 Issue 11, p614
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the study from Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT). After 4-year global trial in chronic obstructive pulmonary disease (COPD), UPLIFT is evaluating the potential of the drug to slow disease progression by reducing the rate of decline in lung function. More specifically, it improves lung function and quality of life and reduces exacerbations and mortality in patients with COPD.
ACCESSION #
35599023

 

Related Articles

  • Staged bilateral single-port thoracoscopic lung volume reduction surgery: A report of 11 cases. MIAO ZHANG; HENG WANG; XUE-FENG PAN; WEN-BIN WU; HUI ZHANG // Experimental & Therapeutic Medicine;Nov2016, Vol. 12 Issue 5, p2851 

    The aim of the present study was to investigate the feasibility and efficacy of staged bilateral single-port thoracoscopic lung volume reduction surgery (LVRS) for patients with chronic obstructive pulmonary emphysema (COPE). Eleven male patients with a mean age of 60.27±12.11 years with...

  • Tiotropium for uncontrolled asthma.  // Neurology Alert;Dec2010 Supplement, p1 

    The article focuses on a study which investigated the therapeutic use of tiotropium, a long-acting anticholinergic inhaler, for patients with chronic obstructive pulmonary disease (COPD).

  • Tiotropium for Uncontrolled Asthma.  // Internal Medicine Alert;12/15/2010 Clinical Briefs, p1 

    The article reports on the findings of a study that suggest that tiotropium, a long-acting anticholinergic inhaler, has been approved for the treatment of chronic obstructive pulmonary disease.

  • New treatment for COPD launched.  // Pulse;9/9/2002, Vol. 62 Issue 34, p4 

    Announces the launch of Spiriva, an anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease by Boehringer Ingelheim and Pfizer in Great Britain.

  • The effect of home‑based inspiratory muscle training on exercise capacity, exertional dyspnea and pulmonary function in COPD patients. Bavarsad, Maryam Bakhshandeh; Shariati, Abdolali; Eidani, Esmaeil; Latifi, Mahmud // Iranian Journal of Nursing & Midwifery Research;Sep/Oct2015, Vol. 20 Issue 5, p613 

    Background: Chronic obstructive pulmonary disease (COPD) is currently the fourth cause of mortality worldwide. Patients with COPD experience periods of dyspnea, fatigue, and disability, which impact on their life. The objective of this study was to investigate the effect of short‑term...

  • ABC of chronic obstructive pulmonary disease. Currie, Graeme P.; Lipworth, Brian J. // BMJ: British Medical Journal (International Edition);6/17/2006, Vol. 332 Issue 7555, p1439 

    The article presents information on inhaled treatment for patients with chronic obstructive airways disease (COPD). According to the article, all patients with COPD should be prescribed a short acting bronchodilator. The article discusses long acting bronchodilators, inhaled corticosteroids,...

  • Safety of Inhaled Anticholinergics for COPD Scrutinized. Elliott, William T. // Critical Care Alert;Nov2008 Pharmacology Watch, p1 

    The article focuses on the safety of inhaled anticholinergics for the treatment of chronic obstructive pulmonary disease (COPD).

  • Tiotropium cost effective in COPD in UK and Belgium.  // PharmacoEconomics & Outcomes News;11/10/2012, Issue 666, p7 

    The article discusses research on adding tiotropium to standard care that references the study "Cost-utility analysis of tiotropium versus usual care in patients with chronic obstructive pulmonary disease (COPD) in the U.K. and Belgium," by R. Hettle et al in the October 2012 issue of...

  • COMMENTARY. Niewoehner, Dennis E. // Evidence Based Medicine;May2003, p74 

    The author discusses aspects of drug effectiveness wherein he recommends that an anticholinergic agent can be combined with beta blocker agonist in the treatment pf patients with chronic obstructive pulmonary disease (COPD).

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics